O.C.G.A.

O.C.G.A. § 33-53-4 (2019)

Exceptions to requirements for coverage

✓ O.C.G.A. (archive.org 2024 item): print volumes of 2004-2024, per-volume vintage; older volumes partly replaced by 2019 Release 73 text; no 2025 or 2026 Acts
Code text and O.C.G.A. statutory annotations on this page reflect the 2019 Official Code of Georgia Annotated (Public.Resource.Org Release 73, 2019-08-21; public domain per Georgia v. Public.Resource.Org, 2020). The Syfert case-law annotations in Notes of Decisions, below, are current.
Find cases: SyfertCases citing this section GA-LEGlegis.ga.gov (official) JustiaJustia CornellLII Search CasesGoogle Scholar

This chapter shall not be deemed to do any of the following:

(1) Require coverage for any drug when the federal Food and Drug Administration has determined the drug’s use to be contraindicated;

(2) Require coverage for an experimental drug not approved for any indication by the federal Food and Drug Administration;

(3) Alter any other law limiting the coverage of drugs that have not been approved by the federal Food and Drug Administration.

History

Code 1981, § 33-53-4, enacted by Ga. L. 1993, p. 539, § 1.

CHAPTER 54 GENETIC TESTING Sec.

Legislative findings and determinations; intent of chapter. Definitions. Purpose of testing; consent required; confidential and privileged information. Prohibited use of information.

Administrative rules and regulations. - Prohibition Against Use of Genetic Information and Requests for Genetic Testing, Official Compilation of the Rules and Regulations of the State of Georgia, Comptroller General, Commissioner of Insurance, Sec. 120-2-8-.24.

Sec.

Use of information in criminal investigation or prosecution authorized. Use of information for scientific research purposes authorized. Applicability of chapters. Violations of chapter.

Annotations

Administrative Rules and Regulations. - Prohibition Against Use of Genetic Information and Requests for Genetic Testing, Official Compilation of the Rules and Regulations of the State of Georgia, Comptroller General, Office of the Commissioner of Insurance, Sec. 120-2-8-.24.

Law reviews. - For comment, "Closing the Gap: Protecting Predictive Neuroscience Information from Health Insurance Discrimination," see 64 Emory L.J. 1433 (2015).

RESEARCH REFERENCES

Am. Jur. 2d. - 23 Am. Jur. 2d, Depositions and Discovery, § 170.

60 Am. Jur. 2d, Patents, § 80.

C.J.S. - 16B C.J.S., Constitutional Law, § 1034 et seq.